Jessica O’Rear

Medicine · Health Sciences

4h-index63citations71works0.42yr avg

OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(65), Cancer Immunotherapy and Biomarkers(59), Monoclonal and Polyclonal Antibodies Research(25), Chronic Lymphocytic Leukemia Research(5), Immunotherapy and Immune Responses(3)

Publications71 total

A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses

Nature Communications·2026Open Access

Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen

1 cited

Nature Communications·2026· 1 citedOpen Access

Design, Structure, and Immunogenicity of a Soluble Prefusion-stabilized EBV gB Antigen

2 cited

2025· 2 citedOpen Access

Figure S8 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S7 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S13 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Data from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S8 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S9 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S6 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Figure S19 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

Table S3 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

2024Open Access

page 1 of 4Next →